跳至主要内容
临床试验/NCT05782816
NCT05782816已完成4 期

Low-Dose Versus High-Dose Oxytocin Dosing for Induction and Augmentation of Labor: A Randomized Control Trial

The University of Texas Medical Branch, Galveston1 个研究点 分布在 1 个国家目标入组 170 人开始时间: 2023年4月17日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
170
试验地点
1
主要终点
Time to Delivery

研究概览

简要总结

The goal of this clinical trial is to compare oxytocin infusion rates for induction and augmentation of labor in nulliparous women. The main question[s] it aims to answer are:

  • Does a high dose oxytocin infusion protocol affect length of induction to delivery interval?
  • Does a high dose oxytocin infusion protocol affect mode of delivery?
  • Does a high dose oxytocin infusion protocol affect maternal and neonatal outcomes?

Participants will be randomized to either low- or high-dose oxytocin groups:

  • The low dose group will receive an infusion to start at 2 milli-units/min and will be increased by 2 milli-units/min every 20 minutes. The maximum rate of infusion is 40 milli-units/min.
  • The high dose group will receive an infusion to start at 6 milli-units/min and will be increased by 6 milli-units/min every 20 minutes. Maximum rate of infusion is 40 milli-units/min.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •Women aged 18-50 years old
  • •Singleton gestation
  • •Nulliparous
  • •Vertex presentation
  • •Gestational age greater than or equal to 37 weeks
  • •No prior uterine surgery
  • •Presents for elective or medically indicated induction of labor
  • •Need for augmentation of labor with oxytocin

排除标准

  • •Previous cervical ripening using non-mechanical methods
  • •Patient unable or unwilling to provide verbal consent
  • •Contraindications to vaginal delivery
  • •Fetal demise or life-limiting anomaly
  • •Allergy to oxytocin
  • •Non-reassuring fetal heart tracing prior to inclusion
  • •Maternal pulmonary edema prior to inclusion
  • •Fetal growth restriction

研究组 & 干预措施

High dose oxytocin

Active Comparator

The high dose oxytocin group will receive a controlled infusion pump at a proximal port on the peripheral IV line. The infusion will start at 6 milli-units/min and will be increased by 6 milli-units/min every 20 minutes. Maximum rate of infusion is 40 milli-units/min. Oxytocin infusion rate is adjusted to maintain adequate uterine contractions.

干预措施: Oxytocin (High dose) (Drug)

Low dose oxytocin

Active Comparator

The low dose oxytocin group will receive a controlled infusion pump at a proximal port on the peripheral IV line. The infusion will start at 2 milli-units/min and will be increased by 2 milli-units/min every 20 minutes. Maximum rate of infusion is 40 milli-units/min. Oxytocin infusion rate is adjusted to maintain adequate uterine contractions.

干预措施: Oxytocin (Low dose) (Drug)

结局指标

主要结局

Time to Delivery

时间窗: Through delivery, on average 24 hours

Induction to delivery time interval

次要结局

  • Mode of Delivery(Through delivery, on average 24 hours)
  • Rate of Primary Cesarean Delivery(Through delivery, on average 24 hours)
  • Maximum Dose of Oxytocin Infusion(Through delivery, on average 24 hours)
  • Rate of Uterine Tachysystole(Through delivery, on average 24 hours)
  • Number of Participants With Postpartum Hemorrhage(From delivery through the postpartum period (average duration approximately 24 hours))
  • Rate of Placental Abruption(Through delivery, on average 24 hours)
  • Number of Participants With Nausea/Vomiting Requiring Antiemetics and Diarrhea(From delivery (average duration approximately 24 hours))
  • Rate of Maternal Infection (Endometritis, Chorioamnionitis)(Through delivery, on average 24 hours)
  • Rate of Serious Maternal Morbidity and Mortality(Through delivery, on average 24 hours)
  • Number of Neonates With One or More of: Perinatal Death, Severe Respiratory Distress Requiring Ventilation, Neonatal Encephalopathy, Neonatal Seizure, Neonatal Sepsis, 5-minute APGAR Score <7, Umbilical Artery Acidemia, Neonatal ICU Admission(From birth through 24 hours)
  • Number of Participants With Neonatal Sepsis (Confirmed With Cultures)(From birth through 24 hours)
  • Rate of Umbilical Artery Acidemia (Base Excess <12)(Through delivery, on average 24 hours)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验